28 February 2025
CVS Group
plc
("CVS" or
the "Company")
Total Voting
Rights
CVS, the UK-listed veterinary group and a
leading provider of veterinary services,
announces that, as of 28 February 2025, the Company's total issued
share capital consists of 71,740,184 Ordinary Shares of 0.2p each
with each one carrying one voting right. The Company holds no
Ordinary Shares in treasury and the total number of voting rights
is therefore 71,740,184.
This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest, or a
change to their interest, in the Company under the FCA's Disclosure
Guidance and Transparency Rules.
Contacts:
Contacts
CVS Group
plc via
Camarco
Richard Fairman, Chief Executive
Officer
Robin Alfonso, Chief Financial
Officer
Paul Higgs, Chief Veterinary
Officer
Peel Hunt LLP (Nominated Adviser
& Joint Broker)
+44
(0)20 7418 8900
Christopher Golden / James Steel /
Andrew Clark / Lalit Bose
Berenberg (Joint
Broker) +44
(0)20 3207 7800
Toby Flaux / Michael Burke / James
Thompson / Milo Bonser
Camarco (Financial
PR)
Ginny Pulbrook
+44 (0)20 3757 4980
Tilly Butcher
Letaba Rimell
About CVS Group
plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of
veterinary services with operations in the UK, and Australia. CVS
is focused on providing high-quality clinical services to its
clients and their animals, with outstanding and dedicated clinical
teams and support colleagues at the core of its
strategy.
The Group now operates c.460 veterinary
practices across its two territories, including specialist referral
hospitals and dedicated out-of-hours sites. Alongside the core
Veterinary Practices division, CVS operates Laboratories (providing
diagnostic services to CVS and third parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and
third-party practices) and an online retail business ("Animed
Direct").
The Group employs c.9,000 personnel,
including c.2,400 veterinary surgeons and c.3,300
nurses.
